About: MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Sector: Healthcare
Industry: Biotechnology
Latest price: $12.56 (+0.16%)
MDWD NASDAQ Mediwound Ltd
Mediwound Ltd share price
MDWD price activity
Last Price
$12.560
Change (24hr)
0.02 USD (0.16%)
Volume
65.57K
Volume (4w avg)
-
Open
$12.50
Day Range
$12.35 - $12.61
Previous Close
$12.54
Last Trade
12 Oct, 8:00 pm GMT+0
Delayed
12 Oct, 8:00 pm GMT+0
MDWD price performance
Delayed
12 Oct, 8:00 pm GMT+0
MDWD Market Signals